Lb Pharmaceuticals Inc

Symbol
LBRX on Nasdaq
Entity
Company
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
575 Madison Avenue, 10022 New York, NY
Phone
917-450-6581
State of incorporation
DE
Fiscal year end
December 31
Category

Emerging growth company
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Lb Pharmaceuticals Inc has filed 55 SEC EDGAR filings since 12/15/2016

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G Open Document Open Filing Sep 18, 2025 005-95235
SCHEDULE 13G Open Document Open Filing Sep 18, 2025 005-95235
4 Open Document Open Filing Sep 16, 2025 Sep 12, 2025
3 Open Document Open Filing Sep 16, 2025 Sep 12, 2025
4 Open Document Open Filing Sep 16, 2025 Sep 12, 2025
4 Open Document Open Filing Sep 16, 2025 Sep 12, 2025
4 Open Document Open Filing 4 Sep 16, 2025 Sep 12, 2025
4 Open Document Open Filing Sep 12, 2025 Sep 10, 2025
4 Open Document Open Filing Sep 12, 2025 Sep 10, 2025
4 Open Document Open Filing Sep 12, 2025 Sep 10, 2025
4 Open Document Open Filing Sep 12, 2025 Sep 10, 2025
4 Open Document Open Filing Sep 12, 2025 Sep 10, 2025
4 Open Document Open Filing Sep 12, 2025 Sep 10, 2025
4 Open Document Open Filing Sep 12, 2025 Sep 10, 2025
4 Open Document Open Filing Sep 12, 2025 Sep 10, 2025
4 Open Document Open Filing Sep 12, 2025 Sep 10, 2025
4 Open Document Open Filing Sep 12, 2025 Sep 10, 2025
4 Open Document Open Filing Sep 12, 2025 Sep 10, 2025
8-K Open Document | Data Open Filing 8-K Sep 12, 2025 Sep 12, 2025 001-42831
424B4 Open Document Open Filing 424B4 Sep 12, 2025 333-289812
3 Open Document Open Filing Sep 11, 2025 Sep 10, 2025
3 Open Document Open Filing Sep 11, 2025 Sep 10, 2025
3 Open Document Open Filing Sep 11, 2025 Sep 10, 2025
S-8 Open Document | Data Open Filing S-8 Sep 11, 2025 333-290180
EFFECT Open Document Open Filing Sep 10, 2025 333-289812
3 Open Document Open Filing Sep 10, 2025 Sep 10, 2025
S-1MEF Open Document | Data Open Filing S-1MEF Sep 10, 2025 333-290182
3 Open Document Open Filing Sep 10, 2025 Sep 10, 2025
3 Open Document Open Filing Sep 10, 2025 Sep 10, 2025
3 Open Document Open Filing Sep 10, 2025 Sep 10, 2025
3 Open Document Open Filing Sep 10, 2025 Sep 10, 2025
3 Open Document Open Filing Sep 10, 2025 Sep 10, 2025
3 Open Document Open Filing Sep 10, 2025 Sep 10, 2025
3 Open Document Open Filing Sep 10, 2025 Sep 10, 2025
3 Open Document Open Filing Sep 10, 2025 Sep 10, 2025
3 Open Document Open Filing Sep 10, 2025 Sep 10, 2025
3 Open Document Open Filing Sep 10, 2025 Sep 10, 2025
CERT Open Document Open Filing Sep 10, 2025 001-42831
8-A12B Open Document Open Filing 8-A12B Sep 9, 2025 001-42831
S-1/A Open Document | Data Open Filing S-1/A Sep 8, 2025 333-289812
S-1 Open Document | Data Open Filing S-1 Aug 22, 2025 333-289812
DRS/A Open Document Open Filing Jul 23, 2025 377-07237
DRS/A Open Document Open Filing Jun 24, 2024 377-07237
DRS Open Document Open Filing May 20, 2024 377-07237
D/A Open Document Open Filing Jan 10, 2024 021-492682
D Open Document Open Filing Sep 21, 2023 021-492682
D/A Open Document Open Filing Nov 23, 2022 021-463476
D Open Document Open Filing Nov 1, 2022 021-463476
D Open Document Open Filing Jul 6, 2022 021-451258
D Open Document Open Filing Sep 1, 2020 021-374620
D Open Document Open Filing Dec 12, 2018 021-327722
D Open Document Open Filing Aug 27, 2018 021-320086
D Open Document Open Filing May 29, 2018 021-313419
D Open Document Open Filing Apr 6, 2017 021-284184
D Open Document Open Filing Dec 15, 2016 021-276363